Aurinia Pharmaceuticals AUPH Total Cost of Revenue

Total Cost of Revenue at other companies

Rogers CorporationROG

$146.4M+5.5%

ANI PharmaceuticalsANIP

$100.16M+34.2%

Opko HealthOPK

$83.56M-22.2%

LQD

Liquidia CorporationLQDA

$1.52M+3.4%

Kiniksa Pharmaceuticals International, plcKNSA

$23.57M+26.7%

Zevra Therapeutics, Inc.ZVRA

$1.53M-87.7%

FAQ

What is Aurinia Pharmaceuticals's total cost of revenue?

Aurinia Pharmaceuticals (AUPH) reported total cost of revenue of $6.56M in Q2 2026.

How has Aurinia Pharmaceuticals's total cost of revenue changed year-over-year?

Aurinia Pharmaceuticals's total cost of revenue decreased by 7.9% year-over-year, from $7.12M to $6.56M.

What is the long-term trend for Aurinia Pharmaceuticals's total cost of revenue?

Over 4 years (2021 to 2025), Aurinia Pharmaceuticals's total cost of revenue has grown at a 133.9% compound annual growth rate (CAGR), from $1.09M to $32.67M.

What does total cost of revenue mean?

The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.